Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Clinical trial NCT00410956 · COMPLETED
Trial details
- NCT number
- NCT00410956
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-09
- Primary completion
- 2024-05-07
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.